Prognostic factors in patients with uterine sarcoma: the SARCUT study.
Ignacio Zapardiel GutiérrezMyriam GraciaRonalds MacuksRosanna MancariPatriciu Achimas-CadariuGiacomo CorradoArnoldas BartuseviciusVladyslav SukhinJuan C MuruzabalPluvio J Coronado MartínBarbara GardellaJurgen M PiekNicole ConcinClemente ArabDimitrios PapatheodorouStephan PolterauerSara IacoponiTeresa NietoMartha C Lopez-SanclementeHanna TrukhanMaria M GilIrina BakinovskayaAlena DalamanavaMarc CucurullDzmitry RovskiLaura BaquedanoLuis Chiva de AgustínMarcin MardasSiarhei Anatolievich MavrichevJaroslav KlatCarlos A Lopez de la ManzanaraYusuf Yildirimnull nullPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Incomplete cytoreduction, tumor persistence, advanced stage, extra-uterine and tumor margin involvement, and the presence of necrosis were relevant prognostic factors significantly affecting overall survival in uterine sarcoma. The presence of lymph vascular space involvement and administration of adjuvant chemotherapy were significantly associated with a higher risk of relapse.
Keyphrases